Clinical and Economic Burden of Patients With Haemophilia A and B in France: Analysis of a Nationwide Claims Database
The clinical burden and costs of haemophilia treatments may be very high especially in patients in prophylaxis and/or with inhibitors.
Authors
- Stephane Bouée (ORCID: https://orcid.org/0000-0001-6838-2680)
- Stéphanie Delienne
- N. Mammar
- Jérémie Rudant (ORCID: https://orcid.org/0000-0002-5843-9417)
- Nicolas Giraud (ORCID: https://orcid.org/0000-0003-2322-339X)
- Francis Fagnani (ORCID: https://orcid.org/0000-0002-0472-3164)
- Véronique Cahoreau
- Maud Beillat (ORCID: https://orcid.org/0009-0004-2825-1394)
- I. Bureau (ORCID: https://orcid.org/0000-0001-6879-6357)
- H Lilliu (ORCID: https://orcid.org/0000-0002-4929-6151)
- Aurélien Lebreton (ORCID: https://orcid.org/0000-0002-1650-0427)
- Laurent Frenzel (ORCID: https://orcid.org/0000-0002-6085-2163)
- Amélie Coumert
- Yasmine Fahfouhi
- Juliette Cottin
- Anaïs Reynaud
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Cemka-Eval (France) (FR)
- Association Française de Chirurgie (FR)
- CHU Dijon Bourgogne (FR)
- Pfizer (France) (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
Publication Details
- Journal
- Haemophilia
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1111/hae.70041
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00